VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Recursion Pharmaceuticals, Inc. (RXRX) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biological Products, (No Diagnostic Substances) · market value about $2.0B · revenue $68.2M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows